Search
Apellis Pharmaceuticals Inc
APLSAdd to Watchlist
41.030USD
0.0000.00%
Close 06/18, 16:00（ET）Quotes delayed by 15 min
5.25BMarket Cap
38.75P/E TTM
Revenue Breakdown
Currency: USDUpdated: Mon, Apr 6
Currency: USDUpdated: Mon, Apr 6
FY2025
FY2025Q4
FY2025Q3
FY2025Q2
FY2025Q1
FY2024
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
By BusinessUSD
Name
Revenue
Proportion
SYFOVRE
586.93M
58.47%
Licensing and other revenue
314.40M
31.32%
EMPAVELI
102.45M
10.21%
Relevant data have not been disclosed by the company yet.
By Business
By Region
By BusinessUSD
Name
Revenue
Proportion
SYFOVRE
586.93M
58.47%
Licensing and other revenue
314.40M
31.32%
EMPAVELI
102.45M
10.21%
